POZEN INC /NC
DelistedCIK 1059790fmd_1BQ4X83BJ28JSQ1K30QT6SB0BXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2015, 23 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|---|
| Total revenues | 32 | 69 | 87 | 5 | 10 | – |
| Realized investment gains (losses) | – | – | – | – | – | (0) |
| Research and development | 22 | 23 | 23 | 12 | 10 | 6 |
| Selling, general and administrative | 18 | 24 | 22 | 19 | 17 | 10 |
| Total operating expenses | 40 | 46 | 45 | 31 | 27 | 16 |
| Interest and investment income | 1 | 1 | 0 | 0 | 0 | 3 |
| Income before taxes | (7) | 23 | 42 | (25) | (17) | (20) |
| Income tax expense | (1) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (7) | 23 | 42 | (25) | (17) | (20) |
| Net income | (7) | 23 | 42 | (25) | (17) | 20 |